Siemens Collaborates With Major Private Hospital In Northeast China
This article was originally published in PharmAsia News
Executive Summary
Siemens China has signed a strategic agreement to establish a partnership with Wekang Medicinal Group, the first private Class III hospital in Northeast China. Under the agreement, Siemens will provide Wekang with a full set of radiological and in vitro diagnostic equipment worth about RMB 70 million ($10.2 million), complemented by leasing services; introduce advanced global experience of hospital management procedures and help medical care staff further their studies in overseas hospitals; and assist Wekang to set up a tumor treatment center in the future. The fully equipped Wekang hospital will go into operation in late 2009. Siemens said it is exploring new collaborative models with local corporations by providing leading healthcare products and solutions. (Click here for more - Chinese Language)
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.